Advancing Precision Approaches to Chronic Obstructive Pulmonary Disease.

Area of Science:

• Pulmonary Medicine
• Genetics
• Biomarkers

Background:

• Chronic Obstructive Pulmonary Disease (COPD) is a complex, heterogeneous lung disease.
• Precision medicine offers a framework to address COPD's heterogeneity through targeted approaches.
• Previous COPD classifications focused on emphysema and chronic bronchitis, but modern methods incorporate advanced data.

Purpose of the Study:

• To review precision medicine strategies for Chronic Obstructive Pulmonary Disease (COPD).
• To highlight the integration of clinical phenotypes, endotypes, and omics biomarkers in COPD research.
• To discuss challenges and future directions for implementing precision medicine in COPD.

Main Methods:

• Leveraging large-scale observational studies like the COPDGene study.
• Analyzing diverse data including clinical information, pulmonary function tests, chest CT scans, and multi-omics (genetics, RNA-sequencing, proteomics).
• Identifying and characterizing COPD subtypes and endotypes based on biological mechanisms and clinical presentation.

Main Results:

• Eosinophilic COPD and alpha-1 antitrypsin deficiency-related emphysema are examples of identified endotypes with specific therapies.
• Subtypes like frequent exacerbators or airway-predominant COPD can be targeted, though underlying biology is complex.
• The COPDGene study provides a rich dataset for advancing COPD precision medicine.

Conclusions:

• Precision medicine approaches are crucial for advancing the understanding and treatment of heterogeneous COPD.
• Integrating omics data with clinical and imaging information is key to defining COPD endotypes.
• Further large-scale longitudinal studies and targeted clinical trials are necessary for the clinical application of precision medicine in COPD.